Literature DB >> 1905691

Pericarditis and myocardial infarctions after Hodgkin's disease therapy.

J M Cosset1, M Henry-Amar, B Pellae-Cosset, P Carde, T Girinski, M Tubiana, M Hayat.   

Abstract

From 1971 to 1984, 499 patients with all stages of Hodgkin's disease received mediastinal irradiation at the Institut Gustave-Roussy by 25 MV photons from a linear accelerator. Thirty-five pericarditis (10-year cumulative incidence rate of 9.5%) and 13 myocardial infarctions (MI) (10-year cumulative incidence rate of 3.9%) were observed. In contrast, no cases were diagnosed in a parallel series of 138 Hodgkin's disease patients treated without mediastinal irradiation during the same period of time (p less than 0.005 for pericarditis, p less than 0.05 for MI). By multivariate analysis, the role of total radiation dose given to the mediastinum and that of fraction size were evaluated, adjusting for age, sex, mediastinal involvement, and type of chemotherapy. The pericarditis risk was significantly increased with total dose greater than or equal to 41 Gy (relative risk (RR) = 3.25, p = 0.006) and with dose per fraction greater than or equal to 3.0 Gy (RR = 2.0, p = 0.06). The myocardial infarction risk was not found to be related to total dose nor to fraction size in this series, possibly because of the small number of events.

Entities:  

Mesh:

Year:  1991        PMID: 1905691     DOI: 10.1016/0360-3016(91)90794-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  24 in total

1.  Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study.

Authors:  C Maunoury; J Y Pierga; H Valette; G Tchernia; J M Cosset; A Desgrez
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Hodgkin's lymphoma. II: Treatment and delayed morbidity.

Authors:  P Carde
Journal:  BMJ       Date:  1992-07-18

3.  Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.

Authors:  Steven H Lin; Ning Zhang; Joy Godby; Jingya Wang; Gary D Marsh; Zhongxing Liao; Ritsuko Komaki; Linus Ho; Wayne L Hofstetter; Stephen G Swisher; Reza J Mehran; Thomas A Buchholz; Linda S Elting; Sharon H Giordano
Journal:  Cancer       Date:  2015-12-30       Impact factor: 6.860

4.  Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Yosuke Kumekawa; Kazuhiro Kaneko; Hiroaki Ito; Toshinori Kurahashi; Kazuo Konishi; Atsushi Katagiri; Taikan Yamamoto; Meiko Kuwahara; Yutaro Kubota; Takashi Muramoto; Yoshihide Mizutani; Michio Imawari
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

5.  Treatment with Corticosteroid for Pericardial Effusion in a Patient with Advanced Synchronous Esophageal and Gastric Cancers following Chemoradiotherapy.

Authors:  Satoshi Osawa; Takanori Yamada; Takeji Saitoh; Takashi Kosugi; Tomohiro Terai; Yasuhiro Takayanagi; Yasushi Hamaya; Ken Sugimoto; Mutsuhiro Ikuma
Journal:  Case Rep Gastroenterol       Date:  2010-07-24

Review 6.  Late complications after treatment for Hodgkin lymphoma.

Authors:  Andrea K Ng
Journal:  Curr Hematol Malig Rep       Date:  2008-07       Impact factor: 3.952

Review 7.  Radiation-Associated Pericardial Disease.

Authors:  Natalie Szpakowski; Milind Y Desai
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

8.  Risk factors for enlargement of cardiac silhouette on chest radiography after radiotherapy for esophageal cancer.

Authors:  Ryuta Sasamoto; Emiko Tsuchida; Tadashi Sugita; Yasuo Matsumoto; Eisuke Abe; Keisuke Sasai
Journal:  Radiat Med       Date:  2006-07

Review 9.  Myocardial infarction in young patients with Hodgkin's disease--potential pathogenic role of radiotherapy, chemotherapy, and splenectomy.

Authors:  K H Scholz; C Herrmann; U Tebbe; J M Chemnitius; U Helmchen; H Kreuzer
Journal:  Clin Investig       Date:  1993-01

Review 10.  [Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?].

Authors:  Frank Lohr; Felix Heggemann; Theano Papavassiliu; Mostafa El-Haddad; Oliver Tomé; Dietmar Dinter; Barbara Dobler; Uta Kraus-Tiefenbacher; Martin Borggrefe; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.